Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The CompuFlo® Epidural System uses Milestone Scientific’s proprietary Dynamic Pressure Sensing Technology® to provide real-time verification of epidural needle placement. This precision-driven ...

Milestone Scientific (MLSS) announced the commercial implementation of its CompuFlo Epidural System at Pain Doctors Medical, a specialized ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

A new drug approved Thursday by the FDA offers pain management but is not addictive. Unlike opioids, it treats pain signals ...

This new nonaddictive alternative is the first of its kind that interrupts the pain signal before it reaches the brain.

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain.Journavx received FDA ...